Physician

Jeffrey Kennedy, MD

According to 2025 Medicare claims, Jeffrey Kennedy, MD (NPI: 1316100837) practices epileptologists in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is REGENTS OF THE UNIV OF CA (NPI: 1356330203; TIN: 680334324) and primary practice location at 95816-5266.

Kennedy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 187 traditional Medicare patients, billed 514 HCPCS/CPT codes, and received $44,201 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 729 prescription claims across 63 beneficiaries totaling $524,860 in drug costs, led by Briviact (Brivaracetam). Open Payments data shows 5 records totaling $21,979. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $61,317 and ending at $44,201. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $181,204 to $524,860. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	271	579	$61,317
2016	239	450	$49,625
2017	290	572	$71,520
2018	219	471	$65,985
2019	245	549	$81,263
2020	192	376	$43,088
2021	175	365	$40,352
2022	176	307	$32,769
2023	196	395	$40,302
2024	187	514	$44,201

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	65	536	$181,204
2016	88	812	$303,304
2017	89	764	$380,554
2018	109	1,275	$890,285
2019	105	1,380	$946,227
2020	88	1,181	$920,732
2021	79	998	$813,613
2022	76	858	$644,903
2023	74	694	$640,967
2024	63	729	$524,860

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	50	116	$166
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	34	52	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	35	42	$60
95816	Measurement of brain wave activity (eeg), awake and drowsy	42	42	$46
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	47	67	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Briviact	Brivaracetam	82	2,835	$143,124
Keppra	Levetiracetam	15	570	$54,635
Oxtellar Xr	Oxcarbazepine	16	1,020	$44,846
Xcopri	Cenobamate	36	1,068	$41,236
Vimpat	Lacosamide	28	960	$34,921

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$422	LivaNova USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$21,557	Marinus Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Kennedy, MD?

Tedicare shows public-source Medicare data for Jeffrey Kennedy, MD (NPI 1316100837), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Kennedy, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey Kennedy, MD?

Jeffrey Kennedy, MD is linked to REGENTS OF THE UNIV OF CA (billing NPI 1356330203) in the available physician profile data.

Does Jeffrey Kennedy, MD have Open Payments data?

Jeffrey Kennedy, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.